Site Map Contact Us Search Back to Home
Pipeline Program

Recent news

Compugen Discloses New Results for Novel Target Candidate for Cancer Immunotherapy |01 October 2014
Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction |29 September 2014
Compugen Appoints Mr. Ari Krashin as Chief Financial Officer|25 August 2014
News on product candidates